HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhongwei Gu Selected Research

dendron

8/2023Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine enables an enhanced cancer combination therapy.
4/2022A Transformable Amphiphilic and Block Polymer-Dendron Conjugate for Enhanced Tumor Penetration and Retention with Cellular Homeostasis Perturbation via Membrane Flow.
9/2021Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy.
6/2021An Amphiphilic PEGylated Peptide Dendron-Gemcitabine Prodrug-Based Nanoagent for Cancer Therapy.
5/2021Dendron-Functionalized Polyglutamate-Pyropheophorbide-a Conjugates as Nanomedicines for Breast Cancer Photodynamic Therapy.
11/2020Glycodendron/pyropheophorbide-a (Ppa)-functionalized hyaluronic acid as a nanosystem for tumor photodynamic therapy.
1/2020DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells.
6/2016A stimuli-responsive Janus peptide dendron-drug conjugate as a safe and nanoscale drug delivery vehicle for breast cancer therapy.
11/2014Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
2/2013The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhongwei Gu Research Topics

Disease

127Neoplasms (Cancer)
05/2024 - 12/2009
26Breast Neoplasms (Breast Cancer)
08/2023 - 01/2012
12Wounds and Injuries (Trauma)
11/2023 - 01/2013
8Neoplasm Metastasis (Metastasis)
12/2023 - 02/2019
8Carcinoma (Carcinomatosis)
10/2023 - 09/2009
5Hepatocellular Carcinoma (Hepatoma)
01/2024 - 01/2011
5Inflammation (Inflammations)
11/2023 - 01/2022
4Liver Neoplasms (Liver Cancer)
01/2023 - 09/2013
4Infections
05/2022 - 02/2005
3Triple Negative Breast Neoplasms
12/2023 - 05/2021
3Lung Neoplasms (Lung Cancer)
11/2023 - 06/2015
3Tissue Adhesions
06/2022 - 12/2020
3Hypoxia (Hypoxemia)
10/2021 - 01/2019
3Hemolysis
06/2016 - 01/2012
2Cicatrix (Scar)
11/2023 - 12/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 03/2021
2Colorectal Neoplasms (Colorectal Cancer)
06/2023 - 10/2022
2Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 11/2020
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2022 - 05/2009
2Melanoma (Melanoma, Malignant)
01/2012 - 01/2012

Drug/Important Bio-Agent (IBA)

26Peptides (Polypeptides)IBA
05/2024 - 02/2013
21Doxorubicin (Adriamycin)FDA LinkGeneric
08/2023 - 12/2009
20Dendrimers (Dendrons)IBA
11/2023 - 06/2012
15PolymersIBA
02/2024 - 08/2012
15EnzymesIBA
02/2024 - 08/2014
14ProdrugsIBA
12/2023 - 07/2013
11Reactive Oxygen Species (Oxygen Radicals)IBA
10/2023 - 07/2013
11Therapeutic UsesIBA
09/2023 - 06/2021
10dendronIBA
08/2023 - 02/2013
10HydrogelsIBA
06/2023 - 12/2009
9Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2011
9Paclitaxel (Taxol)FDA LinkGeneric
11/2023 - 06/2015
9Glutathione (Reduced Glutathione)IBA
11/2023 - 07/2013
9MicellesIBA
08/2015 - 09/2010
81-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2024 - 02/2019
8DisulfidesIBA
01/2022 - 03/2014
8monomethoxypolyethylene glycol (MPEG)IBA
08/2021 - 04/2012
7Hyaluronic Acid (Hyaluronan)IBA
11/2022 - 11/2020
7AcidsIBA
08/2021 - 08/2012
7Antineoplastic Agents (Antineoplastics)IBA
06/2021 - 06/2015
6CollagenIBA
11/2023 - 01/2022
6DNA (Deoxyribonucleic Acid)IBA
10/2022 - 01/2012
5GemcitabineFDA Link
08/2023 - 01/2017
5Contrast MediaIBA
01/2023 - 05/2009
5pyropheophorbide aIBA
11/2021 - 11/2020
5Liposomes (Liposome)IBA
01/2017 - 01/2011
4Immune Checkpoint InhibitorsIBA
05/2024 - 10/2021
4Cathepsin BIBA
08/2023 - 01/2017
4Polysaccharides (Glycans)IBA
06/2022 - 01/2021
4Photosensitizing Agents (Photosensitizers)IBA
02/2022 - 02/2019
4NanocapsulesIBA
01/2018 - 07/2013
3hydroxypropyl methacrylateIBA
11/2023 - 11/2013
3POEGMAIBA
08/2023 - 11/2017
3FluorocarbonsIBA
08/2021 - 10/2016
3Small Interfering RNA (siRNA)IBA
03/2021 - 03/2017
3Heparin (Liquaemin)FDA LinkGeneric
03/2021 - 03/2013
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2018 - 09/2009
2CholesterolIBA
01/2024 - 01/2012
2CopperIBA
12/2023 - 10/2022
2Biocompatible Materials (Biomaterials)IBA
11/2023 - 01/2013
2Cisplatin (Platino)FDA LinkGeneric
11/2023 - 05/2012
2Epirubicin (Ellence)FDA LinkGeneric
09/2023 - 03/2023
2Tryptophan (L-Tryptophan)FDA Link
09/2023 - 03/2015
2N-Acetylneuraminic Acid (Sialic Acid)IBA
09/2023 - 10/2021
2benzeneboronic acidIBA
09/2023 - 10/2021
2ErbB Receptors (EGF Receptor)IBA
08/2023 - 02/2015
2MetalsIBA
06/2023 - 05/2022
2NanovaccinesIBA
04/2023 - 03/2023
2AntigensIBA
03/2023 - 01/2022
2CalreticulinIBA
03/2023 - 10/2021
2phenyl di-n-pentylphosphinateIBA
05/2022 - 11/2021
2Ethylene Glycol (Monoethylene Glycol)IBA
03/2022 - 05/2011
2phytochlorinIBA
02/2022 - 01/2022
2GadoliniumIBA
10/2021 - 02/2021
2Oxygen (Dioxygen)IBA
08/2021 - 02/2019
2Gly-Phe-Leu-GlyIBA
06/2021 - 01/2017
2Messenger RNA (mRNA)IBA
03/2021 - 02/2014
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2021 - 01/2020
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
03/2021 - 04/2018
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
02/2021 - 07/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2017
2Angiogenesis InhibitorsIBA
01/2017 - 03/2013
2LuciferasesIBA
03/2016 - 01/2013
2PlatinumIBA
01/2016 - 12/2014
2Transferrin Receptors (Transferrin Receptor)IBA
02/2015 - 01/2011
2imidazoleIBA
05/2005 - 02/2005
2Clotrimazole (Lotrimin)FDA LinkGeneric
05/2005 - 02/2005
2Antifungal AgentsIBA
05/2005 - 02/2005
1Drug CombinationsIBA
05/2024
1antiglomerular basement membrane antibodyIBA
02/2024

Therapy/Procedure

55Therapeutics
05/2024 - 01/2011
19Drug Therapy (Chemotherapy)
11/2023 - 05/2012
11Photochemotherapy (Photodynamic Therapy)
01/2024 - 02/2019
7Immunotherapy
05/2024 - 10/2021
6Lasers (Laser)
08/2023 - 01/2012
3Radiotherapy
11/2023 - 08/2021
3Precision Medicine
01/2023 - 12/2019
2Suture Techniques
01/2021 - 01/2020
2Intravenous Administration
02/2019 - 01/2011
1Rejuvenation
05/2024